Calcitonin administration in X-linked hypophosphatemia

New England Journal of Medicine

Volumn 364, Issue 17, 2011, Pages 1678-1680

  Liu, Eva S ^a   Carpenter, Thomas O ^a   Gundberg, Caren M ^a   Simpson, Christine A ^a   Insogna, Karl L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE; SALCATONIN;

CALCITONIN BLOOD LEVEL; HUMAN; LETTER; MINERAL METABOLISM; OSTEOMALACIA; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; X LINKED HYPOPHOSPHATEMIC RICKETS;

EID: 79955490495     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1010928     Document Type: Letter

References (4)

1. Carpenter TO, Drezner M. Primary disorders of phosphate metabolism. In: Arnold A, ed. Endotext.org: the endocrine source. South Dartmouth, MA: MDText.com, 2007. (http://www.endotext.org.)
2. van Boekel G, Ruinemans-Koerts J, Joosten F, Dijkhuizen P, van Sorge A, de Boer H. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 2008;158:431-7. (Pubitemid 351405010)
3. Econs MJ, Lobaugh B, Drezner MK. Normal calcitonin stimulation of serum calcitriol in patients with X-linked hypophos-phatemic rickets. J Clin Endocrinol Metab 1992;75:408-11.
4. Gooi JH, Pompolo S, Karsdal MA, et al. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone 2010;46:1486-97.